Michael C Donegan Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael C Donegan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael C Donegan. Michael C Donegan is CAO and VP Finance in TherapeuticsMD, Inc. ($TXMD) and Chief Accounting Officer in TherapeuticsMD, Inc. ($TXMD) and Vice President Finance in TherapeuticsMD, Inc. ($COFF).
Latest Insider Trading Transactions of Michael C Donegan
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | CAO and VP Finance | Option Exercise | M | 0.00 | 19,000 | 0 | 38,000 | |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | CAO and VP Finance | Sell | S | 1.04 | 4,842 | 5,036 | 14,158 | 19 K to 14.2 K (-25.48 %) |
| May 12 2021 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | CAO and VP Finance | Buy | M | 0.00 | 19,000 | 0 | 19,000 | 0 to 19 K |
| Nov 27 2020 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Chief Accounting Of ... | Option Exercise | A | 0.00 | 230,000 | 0 | 230,000 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 0.00 | 57,000 | 0 | 57,000 | |
| Apr 01 2020 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 0.00 | 57,000 | 0 | 57,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 2.73 | 120,000 | 327,600 | 120,000 | |
| Aug 30 2019 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 2.73 | 120,000 | 327,600 | 120,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 5.16 | 100,000 | 516,000 | 100,000 | |
| Mar 19 2018 | TXMD | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 5.16 | 100,000 | 516,000 | 100,000 | |
| Mar 17 2017 | COFF | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 6.83 | 40,000 | 273,200 | 40,000 | |
| Dec 21 2015 | COFF | TherapeuticsMD, In ... | Donegan Michael C | Vice President Fina ... | Option Exercise | A | 8.92 | 100,000 | 892,000 | 100,000 |
Page: 1